Dosing study of esmolol for reducing hemodynamic changes during lightwand intubation

Area of Science:

• Anesthesiology
• Cardiovascular Pharmacology

Background:

• Lightwand intubation offers a convenient alternative to laryngoscopy.
• Tracheal intubation can cause significant hemodynamic changes, including elevated blood pressure and heart rate.
• Understanding interventions to mitigate these changes is crucial for patient safety.

Purpose of the Study:

• To evaluate the efficacy of different esmolol doses in blunting hemodynamic responses to lightwand intubation.
• To compare the effects of esmolol on heart rate, blood pressure, and rate-pressure product.

Main Methods:

• 140 patients undergoing general anesthesia for elective surgery were randomized into four groups.
• Groups received either normal saline (control) or esmolol (0.5, 1, or 2 mg/kg) 2 minutes before lightwand intubation.
• Hemodynamic parameters including blood pressure, heart rate, and rate-pressure product were measured pre- and post-intubation.

Main Results:

• Heart rate elevation was significantly suppressed in the 1 mg/kg and 2 mg/kg esmolol groups compared to the control.
• Rate-pressure product after intubation was significantly reduced in the 2 mg/kg esmolol group versus the control.
• No significant difference in blood pressure changes was noted across groups.

Conclusions:

• Esmolol administration (1-2 mg/kg) prior to lightwand intubation effectively attenuates heart rate elevation.
• A dose of 2 mg/kg esmolol is effective in blunting the rate-pressure product response.
• Esmolol represents a viable pharmacological option to manage hemodynamic stress during lightwand intubation.